Are you Dr. Kim?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 96 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2100 Webster St Ste 326
San Francisco, CA 94115Phone+1 415-885-8600Fax+1 415-885-8680- Is this information wrong?
Summary
- Dr. Kevin Kim, MD is an oncologist in San Francisco, California. He is currently licensed to practice medicine in California, Texas, and Minnesota. He is affiliated with California Pacific Medical Center.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1998 - 2001
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1996 - 1998
University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 1995 - 1996- University of Illinois College of MedicineClass of 1995
Certifications & Licensure
CA State Medical License 2014 - 2026
TX State Medical License 2002 - 2015
MN State Medical License 1996 - 1999- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Imatinib Mesylate in Treating Patients With Metastatic Melanoma Start of enrollment: 2001 Sep 01
- Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma Start of enrollment: 2005 Mar 01
- Sample Collection From Melanoma Patients Start of enrollment: 2006 Jun 13
- Join now to see all
Publications & Presentations
PubMed
- 12 citationsPhase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma.Martin Schuler, Lisa Zimmer, Kevin B Kim, Jeffrey A Sosman, Paolo A Ascierto, Michael A Postow, Filip Y F L De Vos, Carla M L van Herpen, Matteo S Carlino, Douglas B J...> ;Clinical Cancer Research. 2022 Jul 15
- 7 citationsCurrent management of melanoma patients with nodal metastases.Dale Han, Alexander C.J. van Akkooi, Richard J. Straker, Adrienne B. Shannon, Giorgos C. Karakousis, Lin Wang, Kevin B. Kim, Douglas S. Reintgen> ;Clinical & Experimental Metastasis. 2021 May 7
- 183 citationsAdjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomi...Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Andrey Meshcheryakov, Adnan Khattak, M...> ;The Lancet. Oncology. 2021 May 1
- Join now to see all
Press Mentions
Schedule at A GlanceJune 8th, 2015
Professional Memberships
- Member
Hospital Affiliations
California Pacific Medical CenterSan Francisco, California
